Skip to main content

This job has expired

You will need to login before you can apply for a job.

Medical Director, Cardiology- Discovery Medicine

Employer
BioMarin Pharmaceutical Inc.
Location
Working from Home
Start date
May 17, 2021

View more

Job Details

BioMarin is a world leader in delivering therapeutics providing significant benefit to patients who live with serious and life-threatening rare genetic diseases. BioMarin is engaged in the discovery, translation and development of therapies that correct severe pathologic mechanisms and produce meaningful endpoints for clinically relevant improvements in diseases. We therefore seek to discover and develop medicines that profoundly improve the quality of patients’ lives.

BioMarin’s Discovery Medicine is a group of physician-scientists that support pipeline advancement and growth into clinical development.  As an early clinical development function, our group of ‘scientific’ clinicians link research initiatives and technical assessments to areas of development based on fundamental understanding of genetics, molecular mechanisms, disease phenotypes and medical need in specific patient populations. We seek a cardiology-trained physician-scientist to support the early clinical development of a broad portfolio of programs in genetic heart diseases. 

RESPONSIBILITIES:

  • Align mechanistic information with development goals based on genetics, therapeutic approach, technical likelihood of success and medical need
  • Identify high value therapeutic targets for genetic cardiac diseases and contribute clinical expertise to groups involved in disease mapping and pipeline strategy
  • Subject matter expertise in genetic cardiology by keeping current with literature, meetings, and disease pipeline
  • Work with Research, Innovation Accelerator and Business Development to facilitate clinical diligence of new development opportunities
  • Participate in scientific advisory boards convened by BioMarin to support the research initiatives in cardiac genetics
  • Leadership role in nominating, prioritizing and advancing research stage programs
  • Early clinical development representation at cross-functional teams
  • Generate development plans, draft product characterization, first-in-human and proof of concept trial strategy, draft clinical development plans
  • Author biomarker and endpoint strategy for clinical development
  • Early clinical representative in investigative new drug (IND) filing team

QUALIFICATIONS:

  • MD or MD/PhD required
  • Strong record of basic and/or translational research productivity
  • Solid foundation and interest in molecular and population genetics
  • Board certified or eligible in adult or pediatric cardiology
  • Effective at building alliances across functions, based on end-to-end drug development thinking and experience
  • Excellent interpersonal communication skills, able to drive collaborations across a matrixed organization

We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity, sexual orientation, national origin, disability status, protected veteran status, or any other characteristic protected by law.

Company

BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. In 1997, the company was founded to make a big difference in small patient populations, focusing on giving much-needed attention to the underserved communities of those with rare diseases. BioMarin sought to help patients whose voices could not always be heard and treat conditions that were not always in mainstream medical conversations. Throughout its history, BioMarin has worked tirelessly to make a difference by pursuing bold science. The company’s first approved therapy was inspired by a father who refused to accept there was no therapy for his son’s rare diagnosis. That relentless pursuit to change the course of his son’s future through the power of science is at the core of who BioMarin is today.

Through the company’s expertise in genetics and molecular biology, BioMarin has developed eight first or best-in-class targeted therapies that address the root cause of the conditions it seeks to treat, helping to better the lives of those struggling with rare genetic disease. The company’s purposeful and scientifically precise team of physicians and scientists has honed each treatment modality to seek transformative therapies.

Now, BioMarin seeks to make an even greater impact by applying the same science-driven, patient-forward approach that propelled the last 25 plus years of drug development to larger genetic disorders, as well as genetic subsets of more common conditions. Each drug candidate pursued is guided by a fundamental understanding of the genetics and underlying biology of the condition it will address. The company believes that applying its knowledge to make a transformative impact is not just a calling, but an obligation to those who will benefit most. The more innovative solutions developed, the more lives BioMarin can impact.

Company info
Website
Location
California
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert